How Long Will We Have To Wait?

about the book

Every person touched by diabetes wants to know when there will be a cure. A lot of work is going on, but what are the chances of a breakthrough? Targeting a Cure for Type 1 Diabetes is diaTribe's comprehensive overview of where we are and where we're headed in that search.

Rich in detail and written for patients and their families, the report features the latest information on the most promising approaches for curing diabetes. These include immune therapeutics, islet and pancreas transplantation, beta cell regeneration and survival agents, and the artificial pancreas.

With an introduction by Dr. Aaron Kowalski of the JDRF, and with concluding remarks by our Editor in Chief, Kelly Close, Targeting a Cure for Type 1 Diabetes is essential reading for anyone who wants to know more about what a cure might look like or when it will be available. Although a cure may not be right around the corner, this book lays bare the possibilities of all the exciting research now underway.

To buy a copy of Targeting a Cure, visit the ADA's store.

critical acclaim

"Targeting a Cure for Type 1 Diabetes will give you hope that someday struggling with the management of type 1 diabetes will only be a memory."- Richard M. Bergenstal, MD (Executive Director, International Diabetes Center, Minneapolis, MN)

“After reading about Kelly Close and her teams’ incredible journey of discovery, we cannot only continue to dream, but we can open our eyes each morning to a reality that brings us closer, inch by inch, discovery by discovery, to a day when glucose control will be automatic and people with type 1 diabetes will be ‘cured.’”- Francine R. Kaufman, MD (Chief Medical Officer and Vice President, Global Medical, Clinical & Health Affairs, Medtronic; Former President, ADA, Los Angeles, CA)

“The search for the cure, by necessity, is fragmented, sprawling, and fluid, so diaTribe has done a great service by providing a coherent picture of the opportunities and obstacles before us. There is no magic bullet for curing type 1 diabetes, but this book describes the very real ammunition being used to try to achieve that end.”- Irl B. Hirsch, MD (Professor of Medicine, University of Washington School of Medicine, Seattle WA)

“Ever since my diagnosis, I have been reading up on possible cures to type 1 diabetes. With all of the information available, it is easy to get confused about what all of the research actually means. Targeting a Cure for Type 1 Diabetes puts all of that information at your fingertips so you can really see, and more importantly understand, what is happening. Thanks Kelly, and all the other authors for putting together this comprehensive book and showing us possible paths to a diabetes-free future.”- Elizabeth Edelman (Co-Founder and CEO, DiabetesDaily.com)

“Leave it to Kelly Close and her team to not simply synthesize and define what a cure really means, but demystify the tangled web of cure pursuit and research. It is impossible not to come away smarter about the biology and complexity of diabetes and reassured that a cure is entirely possible in my lifetime. A gift to all with diabetes and those that love and care for them.”- Howard Steinberg (Founder and CEO, dLife and LifeMed Media, Westport, CT)

“Kelly and her ever-present team of alchemists have once again managed to distill a disparate array of clinical and research pearls into rich, easily digestible nuggets, this time with an overarching theme of curing type 1 diabetes. The book is a vital, unsparing account of those efforts.”- Howard Zisser, MD (Director of Clinical Research and Diabetes Technology, Sansum Diabetes Research Institute, Santa Barbara, CA)